DA

Danaher

Diagnostics and life sciences

Diversified science and technology conglomerate whose diagnostics segment now includes Masimo, bought for $9.9 billion in June 2026. As Masimo's owner it carries the $818.5 million judgment against Apple while appeals run.

Sign up

Get your curated digest

After email confirmation, you will receive a daily digest of the most relevant news that matter to your portfolio